Delcath Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

NEW YORK, April 4, 2024 /PRNewswire/ -- Delcath Systems, Inc. , an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, announces that the...

Related Keywords

United Kingdom ,United States ,Ben Shamsian Lytham ,Company Compensation Committee ,Compensation Committee ,Company Or Delcath ,Nasdaq ,Prnewswire Delcath Systems Inc ,Delcath Systems Inc ,Drug Administration ,Delcath Systems ,Hepatic Delivery System ,Delivery System ,Important Safety Information ,Boxed Warning ,Relations Contact ,